Completed PHASE2 INTERVENTIONAL 1-arm NCT00868491

Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer

Induction Chemotherapy Followed by Chemoradiation With Cetuximab and Cisplatin for Inoperable Squamous Cell Carcinoma of the Head and Neck

Sponsor: Institute of Oncology Ljubljana

Conditions Head and Neck Cancer

Interventions cetuximab, cisplatin docetaxel, cisplatin, 5-fluorouracil radiotherapy

Updated 6 times since 2017 Last updated: Oct 16, 2024 Started: Mar 31, 2008 Primary completion: Dec 31, 2009 Completion: Oct 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Head and Neck Cancer and is currently completed. Institute of Oncology Ljubljana leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Nov 2024 — Present [monthly]

Completed PHASE2
Sep 2024 — Nov 2024 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institute of Oncology Ljubljana

Data source: Institute of Oncology Ljubljana

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ljubljana, Slovenia